Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Disease that occurs as a consequence of immunosuppression in a recipient of a solid organ transplant, or as a consequence of the transplantation.
Biomarker and diagnostic research for disease related to solid organ transplantation has been reported in the published literature.
No clinical trials have been registered for disease related to solid organ transplantation.
206 publications have been identified in PubMed for disease related to solid organ transplantation. Kisho has analyzed 119 by research type. Research spans Review / Meta-Analysis (53%), Epidemiology / Natural History (23%), and Clinical Trial Publication (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 63 | 53% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:50 AM UTC
Disease patterns and progression |
27 |
23% |
Clinical study results | 12 | 10% |
Patient case studies | 7 | 6% |
Laboratory research | 7 | 6% |
New treatment approaches | 2 | 2% |
Testing and diagnosis research | 1 | 1% |
Sidiropoulou M (2026). [PMID: 41702223](https://pubmed.ncbi.nlm.nih.gov/41702223/). *Transplant Rev (Orlando)*. [Review / Meta-Analysis]
Farid KMN (2026). [PMID: 41879713](https://pubmed.ncbi.nlm.nih.gov/41879713/). *Blood Adv*. [Epidemiology / Natural History]
Te HS (2026). [PMID: 40844852](https://pubmed.ncbi.nlm.nih.gov/40844852/). *Liver Transpl*. [Review / Meta-Analysis]
Dieter R (2026). [PMID: 41769995](https://pubmed.ncbi.nlm.nih.gov/41769995/). *J Pharm Pract*. [Review / Meta-Analysis]
Mouratidou C (2026). [PMID: 42281863](https://pubmed.ncbi.nlm.nih.gov/42281863/). *World J Transplant*. [Review / Meta-Analysis]
Fishman JA (2026). [PMID: 41513043](https://pubmed.ncbi.nlm.nih.gov/41513043/). *Am J Transplant*. [Review / Meta-Analysis]
Ambrosioni J (2026). [PMID: 41088922](https://pubmed.ncbi.nlm.nih.gov/41088922/). *HIV Med*. [Review / Meta-Analysis]
Sinai E (2026). [PMID: 41602586](https://pubmed.ncbi.nlm.nih.gov/41602586/). *JGH Open*. [Case Report / Case Series]
Corrêa LMA (2026). [PMID: 42251798](https://pubmed.ncbi.nlm.nih.gov/42251798/). *Transplant Rev (Orlando)*. [Review / Meta-Analysis]
Nguyen AD (2026). [PMID: 29083720](https://pubmed.ncbi.nlm.nih.gov/29083720/). *Unknown Journal*. [Epidemiology / Natural History]
AI-curated news mentioning disease related to solid organ transplantation
Updated Aug 20, 2026
A systematic review and meta-analysis highlights the transmission risk factors for multidrug-resistant donor-derived infections in solid organ transplantation. This research underscores the need for enhanced screening and management strategies to mitigate these risks.
A narrative review highlights the prevalence and management of herpetic ocular infections in solid organ transplantation. This study provides insights into the challenges faced by transplant recipients and the need for improved therapeutic strategies.
Congress has passed a landmark bill aimed at protecting patient access to specialty pharmacies, crucial for managing complex health conditions such as cancer and rare diseases. This legislation is expected to stabilize the specialty pharmacy infrastructure, enhancing innovation and patient outcomes.
The proposed updates to the Increasing Organ Transplant Access (IOTA) Model aim to enhance organ transplant accessibility and improve performance metrics for Medicare. This initiative reflects ongoing efforts to optimize transplant programs and patient outcomes.